Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Intangibles (2025)

Traws Pharma's Intangibles history spans 1 years, with the latest figure at $2.6 million for Q4 2025.

  • Quarterly results put Intangibles at $2.6 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $2.6 million (changed N/A YoY), and the annual figure for FY2025 was $2.6 million, changed.
  • Intangibles for Q4 2025 was $2.6 million at Traws Pharma, roughly flat from $2.6 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $2.6 million in Q3 2025 to a low of $2.6 million in Q3 2025.